Noel G Carlson Selected Research

Noel G Carlson Research Topics

Disease

13	Multiple Sclerosis 06/2015 - 04/2004
8	Polyuria 01/2019 - 05/2009
7	Nephrogenic Diabetes Insipidus 01/2019 - 05/2009
5	Neoplasms (Cancer) 01/2021 - 10/2010
5	Demyelinating Diseases (Demyelinating Disease) 11/2013 - 04/2004
4	Paraneoplastic Cerebellar Degeneration 01/2020 - 04/2010
3	Polydipsia 01/2017 - 05/2009
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2019 - 01/2018
2	Relapsing-Remitting Multiple Sclerosis 06/2015 - 09/2009
2	Autoimmune Diseases (Autoimmune Disease) 09/2014 - 05/2009
2	Inflammation (Inflammations) 11/2013 - 06/2004
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2021
1	Ataxia (Dyssynergia) 01/2021
1	Cerebellar Ataxia (Dysmetria) 01/2021
1	Encephalomyelitis (Myeloencephalitis) 01/2021
1	Glioma (Gliomas) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2013
1	Disease Progression 05/2013
1	Urinary Tract Infections (Urinary Tract Infection) 01/2013
1	Atrophy 11/2012
1	Adenocarcinoma 04/2010
1	Ureteral Obstruction 03/2010
1	Gliosis 06/2006
1	Optic Neuritis (Retrobulbar Neuritis) 06/2006
1	Chronic Progressive Multiple Sclerosis 12/2004

Drug/Important Bio-Agent (IBA)

7	LithiumIBA 01/2019 - 05/2009
6	AntibodiesIBA 01/2021 - 04/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
6	Aquaporin 2IBA 01/2019 - 03/2010
4	AntigensIBA 01/2021 - 01/2015
3	anti-Yo autoantibodiesIBA 01/2021 - 10/2010
3	Dinoprostone (PGE2)FDA Link 12/2015 - 03/2010
3	Arginine Vasopressin (Argipressin)IBA 12/2015 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 05/2013 - 05/2011
2	Immunoglobulin G (IgG)IBA 01/2021 - 09/2014
2	Adenosine Diphosphate (ADP)IBA 01/2019 - 01/2017
2	Purinergic P2Y2 ReceptorsIBA 01/2018 - 01/2012
2	Clopidogrel (Plavix)FDA Link 01/2017 - 12/2015
2	Aquaporins (Water Channels)IBA 12/2015 - 05/2009
2	Prostaglandins EIBA 01/2012 - 05/2009
2	AutoantibodiesIBA 10/2010 - 04/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2010 - 04/2004
2	ProstaglandinsIBA 12/2009 - 05/2009
2	Daclizumab (Zenapax)FDA Link 09/2009 - 12/2004
2	Monoclonal AntibodiesIBA 05/2009 - 12/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2006 - 06/2004
2	EnzymesIBA 05/2006 - 06/2004
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Natalizumab (Tysabri)FDA Link 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Therapeutic UsesIBA 01/2019
1	Prasugrel Hydrochloride FDA Link 01/2017
1	Sodium Channels (Sodium Channel)IBA 12/2015
1	AldosteroneIBA 12/2015
1	Retinaldehyde (Retinal)IBA 06/2015
1	ANNA-2 antibodyIBA 09/2014
1	ResveratrolIBA 11/2013
1	Vitamin D FDA LinkGeneric 05/2013
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2010
1	salicylhydroxamic acid (SHAM)IBA 03/2010
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 06/2006
1	3-nitrotyrosineIBA 06/2006
1	Protein Isoforms (Isoforms)IBA 05/2006
1	Caspase 3 (Caspase-3)IBA 05/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2006
1	AntioxidantsIBA 01/2006
1	Interleukin-2 Receptor alpha SubunitIBA 12/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2004
1	Glutamic Acid (Glutamate)FDA Link 04/2004
1	Myelin Basic ProteinIBA 04/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2006
1	Plasma Exchange 01/2021
1	Injections 01/2013
1	Lasers (Laser) 06/2004